Market revenue in 2023 | USD 182.7 million |
Market revenue in 2030 | USD 332.1 million |
Growth rate | 8.9% (CAGR from 2023 to 2030) |
Largest segment | Therapeutics |
Fastest growing segment | Diagnostics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Diagnostics, Therapeutics |
Key market players worldwide | Roche, Siemens Healthineers AG ADR, Janssen Pharmaceuticals, Illumina Inc, Quest Diagnostics Inc, 23andMe Holding Co Class A, NeoDiagnostix, International Business Machines Corp, Myriad Genetics Inc, Medtronic PLC, GE HealthCare Technologies Inc Common Stock, Abbott Laboratories, Dakota Software, Biogen Inc, Qiagen NV, ImmunityBio Inc Ordinary Shares |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to precision medicine market will help companies and investors design strategic landscapes.
Therapeutics was the largest segment with a revenue share of 85.82% in 2023. Horizon Databook has segmented the Kuwait precision medicine market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2018 to 2030.
The precision medicine market in Kuwait is witnessing notable growth and transformation, driven by advancements in healthcare technology and a growing emphasis on tailored therapeutic approaches. As Kuwait embraces precision medicine, there is a surge in demand for diagnostic tools, genetic testing, and targeted therapies that consider individual variability in genes, environment, and lifestyle.
The adoption of precision medicine in Kuwait is expected to lead to effective and efficient healthcare delivery, with a focus on optimizing treatment outcomes while minimizing adverse effects. The market is witnessing increased collaborations between healthcare providers, pharmaceutical companies, and technology firms to integrate genomic data into clinical decision-making.
In addition, international healthcare providers are coming forward to invest in the country due to substantial market potential. Entry of such players is further estimated to leverage market growth in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait precision medicine market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait precision medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account